Recruiting
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
NCT06679270
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Familial Partial Lipodystrophy, Genetic Diseases, Inborn, +10 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Flourish Research Boca Raton, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of Michigan Ann Arbour, Michigan, United States